Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2024-02-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
$120.8m
reported value
+25.4% vs Q3 2023
32positions
74.2%in top 10
4 new
9 added
1 reduced
9 sold out
vs Q3 2023
Holdings, Q4 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $21.0m17.38% | Unchanged |
| ALDEYRA THERAPEUTICS INC ALDX | $19.2m15.92% | Added +2.4m |
| APPLIED THERAPEUTICS INC APLT | $18.3m15.19% | Added +312.6k |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $8.5m7.02% | Unchanged |
| GLOBAL X FDS SIL | $5.0m4.13% | Added +86.3k |
| HOOKIPA PHARMA INC COM | $4.5m3.70% | Unchanged |
| VERONA PHARMA PLC VRNA | $4.0m3.29% | Unchanged |
| SILVERCREST METALS INC SIL | $3.1m2.55% | Added +60.0k |
| AGNICO EAGLE MINES LTD AEM | $3.0m2.52% | Added +15.5k |
| SEABRIDGE GOLD INC COM | $3.0m2.48% | Unchanged |
| WHEATON PRECIOUS METALS CORP WPM | $3.0m2.45% | Added +12.5k |
| VANECK ETF TRUST GDX | $2.8m2.36% | Unchanged |
| KINROSS GOLD CORP KGC | $2.7m2.20% | Unchanged |
| ENTERA BIO LTD ENTX | $2.3m1.93% | Added +1.4m |
| ALTIMMUNE INC ALT | $2.2m1.86% | New |
| EQUINOX GOLD CORP EQX | $2.1m1.70% | Unchanged |
| VANECK ETF TRUST GDXJ | $2.0m1.67% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.7m1.38% | Unchanged |
| VISA INC V | $1.3m1.04% | Unchanged |
| CVS HEALTH CORP CVS | $1.1m0.95% | Unchanged |
| THERMO FISHER SCIENTIFIC INC TMO | $1.1m0.92% | Unchanged |
| MAG SILVER CORP MAG | $1.1m0.91% | Reduced -55.0k |
| ALAMOS GOLD INC NEW AGI | $1.1m0.89% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $1.0m0.84% | Unchanged |
| PHILIP MORRIS INTL INC PM | $1.0m0.84% | New |
| ISHARES TR ITA | $968.5k0.80% | New |
| NEW PAC METALS CORP NEWP | $926.4k0.77% | Added +353.3k |
| ROYAL GOLD INC RGLD | $913.2k0.76% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $893.8k0.74% | Added +200.0k |
| MEREO BIOPHARMA GROUP PLC MREO | $370.1k0.31% | New |
| Orgenesis, Inc. COM | $317.4k0.26% | Unchanged |
| OPUS GENETICS INC IRD | $301.0k0.25% | Unchanged |
Sold out since Q3 2023
| Security | Value then |
|---|---|
| FRANCO NEV CORP FNV | $1.9m14.5k shares |
| FIRST MAJESTIC SILVER CORP AG | $1.4m275.0k shares |
| ALTRIA GROUP INC MO | $954.5k22.7k shares |
| LOCKHEED MARTIN CORP LMT | $879.3k2.1k shares |
| PAN AMERN SILVER CORP PAAS | $783.1k54.1k shares |
| OSISKO GOLD ROYALTIES LTD | $732.0k400.0k shares |
| AMYLYX PHARMACEUTICALS INC AMLX | $453.6k24.8k shares |
| OMEGA THERAPEUTICS INC | $372.0k173.0k shares |
| BIOXCEL THERAPEUTICS INC | $151.8k60.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |